The oversubscribed second fund plans to deploy capital across 12 to 15 companies, with individual investments of €20 to €50 million focused on US and global market expansionPARIS & SAN ...

Sportradar Group AG faces securities fraud allegations that it aided and abetted illegal gambling and derived a substantial portion of its revenue from such activities, leading to a stock drop of 22%; ...

Fast-growth biopharma startup develops groundbreaking product pipeline to target oral health epidemicMINNEAPOLIS--(BUSINESS WIRE)--#periodontaldisease--Twin Cities-based ProEncia Biotechnology, a ...

New hire accompanied by the promotion of Chris Weber as Chief Strategy OfficerCHICAGO, NEW YORK, & SAN DIEGO--(BUSINESS WIRE) ...

Study Showed Smart Stylet Accurately Identified Cancer in the Lung, with Potential Implications for Improving Biopsy YieldPARIS--(BUSINESS WIRE)--#cancer--Sensome, the pioneer of microsensing ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced the successful completion of an ...

Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomesSAN FRANCISCO--(BUSINESS WIRE)--Blank Bio, an applied AI research lab ...

Portal Innovations, in partnership with the New Brunswick Development Corporation (DEVCO) and HELIX, today announced that Johnson & Johnson has secured naming rights to the Johnson & Johnson Exchange ...

Two appointments add drug development and defense-sector expertise to Ladder Bio’s Board as the company advances its Spiroligomer™ platformBLUE BELL, Pa.--(BUSINESS WIRE)--Ladder Bio, Inc., a ...

Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and ...

Diversified Bookings Span Eight Verticals, Led by Critical Infrastructure and Retail & ConsumerSUNNYVALE, Calif.--(BUSINESS WIRE)--$KSCP #security--Knightscope, Inc. (NASDAQ: KSCP), a managed service ...

Dr. Angelov brings extensive industry experience across multiple therapeutic areasSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company ...